行情

LMNX

LMNX

路明克斯
NASDAQ

实时行情|Nasdaq Last Sale

28.15
+1.10
+4.07%
盘后: 28.15 0 0.00% 16:41 04/02 EDT
开盘
27.01
昨收
27.05
最高
28.32
最低
27.00
成交量
39.62万
成交额
--
52周最高
30.90
52周最低
17.35
市值
12.71亿
市盈率(TTM)
-119.9915
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测LMNX价格均价为24.00,最高价位32.00,最低价为18.00。

EPS

LMNX 新闻

更多
  • Luminex: Making A Difference
  • Seeking Alpha - Article · 1天前
  • FDA OKs emergency use of 2-minute coronavirus test
  • seekingalpha · 2天前
  • Luminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 Test
  • PR Newswire · 2天前
  • Luminex up 9% premarket on BARDA contract to develop SARS-CoV-2 test
  • Seeking Alpha - Article · 2天前

所属板块

先进医疗设备和技术
+4.07%
医疗设备和用品
+3.33%

热门股票

代码
价格
涨跌幅

LMNX 简况

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease segments. The Company has a range of instruments using its xMAP technology, which includes its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to a range of testing laboratories.
展开

微牛提供Luminex Corporation(NASDAQ-LMNX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的LMNX股票新闻,以帮助您做出投资决策。